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An Inducible Transgene Expression System for Regulated
Phenotypic Modification of Human Embryonic Stem Cells
JI-DONG FU,1,2 YUNJOON JUNG,3 CAMIE W. CHAN,2,4 and RONALD A. LI,1–4
ABSTRACT
Self-renewing pluripotent human embryonic stem (hES) cells are capable of regenerating such non-
dividing cells as neurons and cardiomyocytes for therapies and can serve as an excellent experi-
mental model for studying early human development. Both the spatial and temporal relationships
of gene expression play a crucial role in determining differentiation; to obtain a better understanding
of hES cell differentiation, it will be necessary to establish an inducible system in hES cells that
enables specific transgene(s) to reversibly and conditionally express (1) at specific levels and (2) at
particular time points during development. Using lentivirus (LV)-mediated gene transfer and a tetra-
cycline-controlled trans-repressor (TR), we first established in hES cells a doxycycline (DOX)-in-
ducible expression system of green fluorescent protein (GFP) to probe its reversibility and kinetics.
Upon the addition of DOX, the percentage of GFP hES cells increased time dependently: The time
at which 50% of all green cells appeared (T50on) was 119.5  3.2 h; upon DOX removal, GFP ex-
pression declined with a half-time (T50off) of 127.7  3.9 h and became completely silenced at day
8. Both the proportion and total mean fluorescence intensity (MFI) were dose-dependent (EC50 
24.5  2.2 ng/ml). The same system when incorporated into murine (m) ES cells similarly exhibited
reversible dose-dependent responses with a similar sensitivity (EC50  49.5  8.5 ng/ml), but the
much faster kinetics (T50on  35.5  5.5 h, T50off  71.5  2.4 hours). DOX-induced expression of
the Kir2.1 channels in mES and hES cells led to robust expression of the inwardly rectifying potas-
sium (K) current and thereby hyperpolarized the resting membrane potential (RMP). We con-
clude that the LV-inducible system established presents a unique tool for probing differentiation.
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INTRODUCTION
HUMAN EMBRYONIC STEM (hES) cells, isolated fromthe inner cell mass (ICM) of the human blastocyst,
are capable of self-renewing while maintaining the
pluripotency to differentiate into the three germ layers
(i.e., ectoderm, mesoderm, and endoderm) and their cor-
responding derivatives [1]. In addition to their potential
of regenerating such nondividing, highly specialized cells
as neurons and cardiomyocytes for cell-based therapies
[2,3], hES cells can also serve as an excellent experi-
mental model for studying the very poorly defined hu-
man organogenesis. Among many factors, both the spa-
tial and temporal relationships of gene expression are
known to play a crucial role in determining differentia-
tion during development. Indeed, differentiation is a dy-
namic process that involves the precise regulation of nu-
merous genes, proteins, transcription factors, etc; often,
the same genes are repeatedly turned on and off with dis-
tinct roles during different developmental stages [4–6].
To obtain a better understanding of hES cell differentia-
tion, it will be necessary to establish an inducible system
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in hES cells that enables specific transgene(s) to re-
versibly and conditionally express (1) at specific levels
and (2) at particular time points during development so
as to dissect the underlying molecular mechanisms. Re-
cently, we discovered the presence of several specialized
ion channels in pluripotent murine (m) and hES cells
whose functional activities influence proliferation [7].
Here we conjecture that a dose-dependent, ligand-in-
ducible system [8,9] can provide a flexible approach for
controlling ectopic, for example, a reporter protein such
as green fluorescent protein (GFP), or endogenous trans-
gene expression in hES cells.
Using lentivirus (LV)-mediated gene transfer [10,11]
and a tetracycline (tet)-controlled trans-repressor (TR)
from Escherichia coli [12], we initially established an in-
ducible expression system of GFP in mES and hES cells
to probe in detail its reversibility and kinetics and to re-
veal any species similarities and differences. Subse-
quently, we studied the functional consequences of con-
ditionally expressing Kir2.1 channels, also called the
inwardly rectifying potassium (K) current or IK1, a key
player that governs cellular excitability [13] in pluripo-
tent hES cells. During the preparation of this work, a tet-
inducible expression system was similarly and indepen-
dently established in hES cells [14]. Our present study
differs in several major ways: (1) The detailed dose-de-
pendence and kinetics of transgene expression in both
mES and hES cells were reported here but not in the pre-
vious study. This information is crucial for designing fu-
ture experiments. (2) We provide the first demonstration
that an endogenous gene can be inducibly expressed in
hES cells for altering their functional phenotypes. (3) We
emphasize electrophysiology of mES and hES cells, built
on our own previous report.
METHODS
Lentiviral vector plasmid construction and production
The plasmids pLV-THM-GFP and pLV-TR-KRAB-IRES-
dsRed (Fig. 1A) were kind gifts of Dr. Didier Trono (Univer-
sity of Geneva, Geneva, Switzerland). The drug-inducible sys-
tem was a two-vector one that has been previously described
[8]. Briefly, TR-KRAB is a tetracycline-controlled fusion pro-
tein that contains the TR fused to the Krüppel-associated box
(KRAB) domain of human Kox1 [12]. KRAB, a 75-amino-acid
transcriptional repression module in many zinc finger-contain-
ing proteins, suppresses transcription within 3 kb from its bind-
ing site in an orientation-independent manner [12,15–17]. When
fused to the DNA-binding domain of TR, KRAB can modulate
transcription from an integrated promoter juxtaposed with the
tet operator (tetO) sequence [15–17]. In the absence of doxy-
cycline (DOX), TR-KRAB binds specifically to tetO and
thereby suppresses any nearby promoter(s). By contrast, the
presence of DOX will sequester TR-KRAB away from tetO to
enable transgene expression (Fig. 1B) [8].
In all cases, the ubiquitously active promoter EF-1 was cho-
sen to drive the transgene to avoid silencing in undifferentiated
hES cells. To generate pLV-THM-Kir2.1-GFP (Fig. 1A), the
GFP of pLV-THM-GFP was replaced with the fusion protein
Kir2.1-GFP. The recombinant lentiviruses were produced by
transient transfection of HEK293T cells, as previously de-
scribed [18]. Briefly, the lentiviral plasmids p8.91, pMD.G,
and pLV-THM-GFP or pLV-THM-Kir2.1GFP or pLV-TR-
KRAB-dsRed (2:1:3 mass ratio) were co-transfected into
HEK293T cells seeded at a density of 6  106 cells per 10-cm
dish 24 h prior to transfection. The supernatant containing
lentiviral particles were harvested at 24 and 48 h post-trans-
fection and stored at 80°C before use.
Maintenance and transduction of mouse 
and human ES cells
The H1 (WiCell, Madison, WI) hES cell line was main-
tained on irradiated mouse embryonic fibroblasts (MEFs) and
propagated as previously described [1,10]. Briefly, the culture
medium consisted of Dulbecco’s modified Eagle’s medium
(DMEM)/F12 (Invitrogen Corp., Carlsbad, CA) supplemented
with 15% knockout (KO) serum replacer, 1 mM L-glutamine,
0.1 mM -mercaptoethanol, 1% nonessential amino acids, and
4 ng/ml fibroblast growth factor- (FGF-). Cells were grown
in six-well plates and passaged by collagenase digestion and
mechanical dissociation. The resultant suspension was plated
on fresh MEFs at a ratio of 1:5. The culture medium was
changed daily. The D3 mES cell line was cultivated on irra-
diated MEFs in the presence of leukemia inhibitory factor
(LIF), as previously described [7,19]. The culture medium
consisted of DMEM supplemented with 15% fetal bovine
serum (FBS) serum (Hyclone, Logan, UT), 1 mM L-glutamine,
0.1 mM -mercaptoethanol, 1% nonessential amino acids, 20
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FIG. 1. (A) Schematic representation of the LV-based DOX-
inducible transgene expression system. (B) In the absence of
DOX (i.e., DOX), TR-KRAB binds to tetO and thereby sup-
presses EF-1 -mediated transcription. In the presence of DOX
(DOX), TR-KRAB cannot bind to tetO and hence allows gene
expression.
U/ml penicillin, and 20 g/ml streptomycin (Invitrogen,
Carlsbad, CA).
For stable lentiviral transduction, a single-cell suspension of
mES cells and a small-cluster (1,000 cells per cluster) culture
of H1 hES cells were generated by trypsin and collagenase
treatment, respectively. Viral supernantants were added at a fi-
nal concentration of 100,000 TU/ml with 8 mg/ml Polybrene;
mES and hES cells were incubated in suspension for 2–4 h, fol-
lowed by plating on MEFs. LV-TR-KRAB-IRES-dsRed and
LV-THM-GFP or LV-THM-Kir2.1GFP were co-introduced
into mES and hES cells successively in the same order. dsRed
and/or GFP cells were identified by their epifluorescence and
sorted by MoFlo (Dako, Ft. Collius, CO). Co-transduced mES
and hES cells were cultured in the presence or absence of DOX
(Sigma) at the concentrations specified.
FACS analysis
The expression of GFP was assessed by flow cytometry us-
ing FACScan (CyANADP, Dako-Cytomation). The percentage
of GFP cells and mean fluorescence intensity (MFI) of GFP
were measured. For analyzing stage-specific embryonic anti-
gen-1 (SSEA-1) expression, the single-cell suspension was
stained by mouse anti-SSEA-1 monoclonal antibody (Chemi-
con), followed by staining with allophycocyanin- (APC) con-
jugated rat anti-mouse immunoglobulin M (IgM) monoclonal
antibody (BD Pharmingen). Purified mouse IgM,  monoclo-
nal immunoglogulin isotype was used as negative control.
Electrophysiological characterization
Electrophysiological experiments were performed using the
whole-cell patch-clamp technique with an Axopatch 200B am-
plifier and the pClamp9.2 software (Axon Instruments Inc., Fos-
ter City, CA). A xenon arc lamp was used to view GFP fluo-
rescence at 488/530 nm (excitation/emission) [7,20]. Patch
pipettes were prepared from 1.5-mm thin-walled borosilicate
glass tubes using a Sutter micropipette puller P-97 and had typ-
ical resistances of 4–6 M when filled with an internal solu-
tion containing 110 mM K aspartate, 20 mM KCl, 1 mM
MgCl2, 0.1 mM Na-GTP, 5 mM Mg-ATP, 5 mM Na2-phos-
phocreatine, 1 mM EGTA, and 10 mM HEPES, pH adjusted to
7.3 with KOH. The external Tyrode’s bath solution consisted
of 140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 10
mM glucose, and 10 mM HEPES, pH adjusted to 7.4 with
NaOH. Voltage- and current-clamp recordings were performed
at 37°C. To record the resting membrane potential (RMP), cells
were held at 0 pA. For eliciting ionic currents, cells were held
at a 30-mV potential and pulsed from 0 mV to 140 mV
with 10-mV increments for 2 sec, followed by a 1-sec 100-
mV pulse. IK1 was defined as 1 mM Ba2-sensitive currents.
Measurement of membrane potential by using FLIPR
The FLIPR membrane potential assay kit (Molecular De-
vices, Sunnyvale, CA) was employed to assess the RMPs of
mES and hES cells. Cells were loaded for 15 min with FLIPR
Membrane Potential (FMP) dye, which is superior to the con-
ventional bisoxonol fluorescent dye DiBAC(4)(3) [21], ac-
cording to the manufacturer’s protocol, and the fluorescence
was measured by the microplate reader (TECAN, SAFIRE).
The fluorescence intensity of FMP reflects the membrane po-
tential of FMP-loaded cells [21].  fluorescence is the difference
in fluorescence between treated and untreated cells and was
used as an index for changes in the RMP.
Cell proliferation assay
A total of 1  105 mES cells were cultivated on irradiated
MEFs in 12-well plates in the presence of LIF. After 24 h of
incubation, cells were digested into single cells, and the cell
counts were assessed by the cytometer chamber. Cell viability
was determined in 96-well plates using a colorimetric 3-(4, 5-
dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT)
kit (Chemicon). Briefly, 50,000 cells were plated in 96-well
plates at 37°C for 24 h. Then 10 l of MTT labeling reagent
(5 mg/ml in PBS) was added to each well, followed by incu-
bation at 37°C for 4 h. Solubilization solution (100 l) was
added to dissolve the formazan crystals that formed. Ab-
sorbances at 570 nm were read by a spectrophotometer.
Statistics
All data are presented as mean  SEM. Statistical signifi-
cance was defined as p  0.05 by unpaired Student’s t-test.
RESULTS
Reversibility and kinetics of doxycycline-induced
GFP expression in mES cells
As a first step, we stably co-transduced mES cells with
LV-TR-KRAB-IRES-dsRed and LV-THM-GFP (cf.
Fig.1). Figure 2A shows that untransduced, control wild-
type (WT) mES cells did not fluoresce. By contrast, co-
transduced mES cells were always dsRED, as antici-
pated from the constitutive promoter activity of EF-1.
In the absence of DOX, co-transduced mES cells did not
display any GFP expression. When the same cells were
treated with DOX (1 g/ml), GFP mES cells could be
observed as soon as 24 h later; in the presence of DOX,
the percentage of GFP mES cells continued to increase
in a time-dependent manner before a plateau of 80%
was reached after 4–5 days (Fig. 2B; from three inde-
pendent different reactions). The time at which 50% of
all green cells appeared (T50on) was 35.5  5.5 h (n 	
3). Upon DOX removal, GFP expression started to de-
cline after 36 h with a half-time (T50off) of 71.5  2.4
h and became completely silenced 4 days later (n 	 3,
Fig. 2A,C).
Dose-dependent DOX-induced GFP 
expression in mES cells
Figure 3, A and B, shows the effect of a range of DOX
concentrations on the GFP expression of LV-TR-KRAB-
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IRES-dsRed/LV-THM-GFP co-transduced mES cells
when assessed at days 2, 4, and 8. At all of these time
points, no GFP expression could be detected for 0, 3, and
10 ng/ml; GFP mES cells were observed with 20 ng/ml
DOX, and the percentage increased dose-dependently be-
fore leveling at 100 ng/ml. Higher concentrations (300
ng/ml, 1 g/ml, and 3 g/ml) did not further increase the
percentage of GFP mES cells. Unlike the proportion,
the total mean fluorescence intensity (MFI) elevated from
10 ng/ml to 300 ng/ml at all of days 2 (solid squares; Fig.
3C), 4 (open triangles; Fig. 3C), and 8 (solid circles; Fig.
3C). Figure 3D shows the normalized dose-dependent re-
lationships for MFI. The effective concentrations at
which 50% of the maximum EFI (EC50) was attained
were statistically identical (p 
 0.05): 47.5  2.3,
46.5  1.0, and 50.4  1.0 ng/ml for days 2, 4, and 8,
respectively.
Similarities and differences between murine and
human ES cells
Although mES and hES cells share a number of sim-
ilarities, significant differences are known to exist. To
employ the DOX-inducible system described above for
hES cell studies, the detailed dose-dependence and ki-
netics of these cells need to be characterized. Thus, we
stably co-transduced hES cells with the same lentiviruses,
LV-TR-KRAB-IRES-dsRed and LV-THM-GFP. As an-
ticipated, co-transduced but not control hES cells were
always dsRED (Fig. 4A). Upon the addition of 1 g/ml
DOX, co-transduced hES cells became GFP time de-
pendently after an initial 3-day lag (vs. 24 h for mES
cells). The maximum percentage of 90% GFP hES
cells, comparable to that of co-transduced mES cells, was
reached at around day 10 with a T50on of 119.5  3.2 h
FU ET AL.
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FIG. 2. The LV-based DOX-inducible system in mouse ES cells. (A) Representative images of WT and LV-THM-GFP/LV-
TR-KRAB-dsRed co-transduced mouse ES cells in presence () or absence () of DOX (1 g/ml) as indicated. GFP expres-
sion was completely reversible with virtually no expression leakage upon withdrawal of DOX (/DOX). Bar, 50 m. (B) Rep-
resentative FACS analyses (upper) and the kinetics (lower) of inducible GFP expression of co-transduced mouse ES cells at
different time points after DOX treatment (1 g/ml). (C) Representative FACS analyses (upper) and the corresponding decay ki-
netics (lower) of GFP disappearance after DOX withdrawal.
(Fig. 4B); GFP silencing did not occur until 3 days after
DOX was withdrawn, and was completed at day 8 with
a T50off of 127.7  3.9 h (Fig. 4C). Collectively, these
results indicate that the responses of the hES cells to the
addition and removal of DOX were significantly slower
than their mouse counterpart.
We also investigated the effects of different DOX
concentrations on LV-TR-KRAB-IRES-dsRed/LV-
THM-GFP co-transduced hES cells (Fig. 5). No GFP
hES cells were observed for 0, 3, 6, and 8 ng/ml but 10
ng/ml or higher at days 7 and 14; the percentage of
GFP hES cells increased dose-dependently and lev-
eled at 30 ng/ml (Fig. 5A,B). Similar to mES cells,
higher DOX concentrations (i.e., 60 ng/ml, 100 ng/ml,
300 ng/ml, and 1 g/ml) did not further increase the to-
tal percentage of GFP hES cells (Fig. 5A–C). How-
ever, the total MFI increased from 10 to 100 ng/ml at
both days 7 and 14 (Fig. 5C). The EC50 values were
26.0  2.2 and 23.7  1.7 ng/ml, respectively (p 

0.05; Fig. 5D). Taken collectively, the inducible system
mediated by LV-TR-KRAB-IRES-dsRed and LV-
THM-GFP when incorporated into hES cells exhibited
reversible dose-dependent responses with a sensitivity
similar to mES cells, albeit the kinetics were much
slower. All the parameters assessed for mES and hES
cells are summarized in Table 1.
Altering the electrophysiological properties 
of ES cells via conditional expression 
of Kir2.1 channels
Recently, we reported the presence of functional ion
channels in mES and hES cells [7]. To employ the inducible
system described above for conditionally altering electro-
physiological phenotypes, we co-transduced mES cells
with LV-TR-KRAB-dsRed2 and LV-THM-Kir2.1-GFP
(see Materials and Methods). The endogenous gene Kir2.1,
which encodes for the inwardly rectifying K current (IK1),
was chosen because IK1 is known to play a pivotal role in
development (e.g., synaptogenesis) [22] as well as the prop-
erties of various terminally differentiated cell types, from
neurons [23] to cardiomycoytes [24,25]. Functionally, IK1
exerts its effects by stabilizing the RMP, which in turn 
governs cell cycle [26], excitability [27], and other related
processes [13]. Figure 6A shows that GFP signals were 
observed only in LV-THM-Kir2.1-GFP/LV-TR-KRAB-
dsRed2-co-transduced mES incubated with DOX (1
g/ml). Ba2-sensitive IK1 could be recorded only in DOX-
treated co-transduced mES cells but not WT or co-trans-
duced mES without DOX (Fig. 6B). With DOX treatment,
the RMP became significantly hyperpolarized (p  0.001)
from 0.9  1.6 mV (n 	 16) of control mES cells (i.e., both
WT and untreated co-transduced, whose RMPs were sta-
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FIG. 3. (A) Representative FACS analyses of GFP expression of co-transduced mouse ES cells at days 2 and 8 after treatment
with different concentrations of DOX. (B) The dose–response relationships for the % of GFP mES cells at days 2, 4, and 8.
(C) The dose–response relationships for the MFI at days 2, 4, and 8. (D) The normalized dose–response relationships for MFI.
tistically identical; p 
 0.05) to 61.1  1.5 mV (n 	 8)
after Kir2.1 expression was induced by 1 /ml DOX (Fig.
6C; squares and triangles, respectively). Similar to the ex-
pression of GFP alone (cf. Fig. 2), the functional effect of
Kir2.1 expression on RMP was highly DOX-dependent.
Figure 6C also shows that the change in FMP fluorescence
density increased with elevating DOX concentrations (from
10 to 100 ng/ml). These changes mirrored the changes in
electrophysiological properties as assessed by whole-cell
current-clamp recordings [21] as well as the level of GFP
signal (of the fusion protein Kir2.1-GFP; Fig. 6D). The ex-
pression of SSEA-1 was statistically identical before and
after DOX treatment (Fig. 6E; p 
 0.05), indicating that
pluripotency was unaffected by Kir2.1-GFP overexpres-
sion. Indeed, co-transduced mES cells could be readily dif-
ferentiated into the germ layer derivatives (including car-
diomyocytes; data not shown), indicating that pluripotency
was not affected. Additionally, cell proliferation and me-
tabolism were also not different before and after induction
by DOX (p 
 0.05; Fig. 6F,G).
Similar to mES cells, Kir2.1-GFP could be inducibly ex-
pressed in hES cells. Electrophysiological recordings of
LV-THM-Kir2.1-GFP/LV-TR-KRAB-dsRed2-co-trans-
duced hES cells confirmed that Kir2.1 channels were ex-
pressed and functional (Fig. 6H, right). As anticipated, their
RMP was also hyperpolarized (41.4  2.1 mV, n 	 16
vs. 4.2  1.3 mV, n 	 28 of control, p  0.001; Fig. 6H).
DISCUSSION
Mammalian ES cells were first derived from murine blas-
tocysts over a quarter century ago [28,29]. This landmark
achievement led to the subsequent generation of transgenic
FU ET AL.
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FIG. 4. The LV-based DOX-inducible system in human ES cells. (A) Representative images of WT and LV-THM-GFP/LV-
TR-KRAB-dsRed co-transduced human ES cells in presence () or absence () of DOX (1 g/ml) as indicated. GFP expres-
sion was completely reversible with virtually no expression leakage upon withdrawal of DOX (/ DOX). Bar, 100 m. (B)
Representative FACS analyses (upper) and the kinetics (lower) of inducible GFP expression of co-transduced human ES cells at
different time points after DOX treatment (1 g/ml). (C) Representative FACS analyses (upper) and the corresponding decay ki-
netics (lower) of GFP disappearance after DOX withdrawal.
animals with targeted gene mutations [30], revolutionizing
developmental biology, animal disease models, and genet-
ics. In 1998, Thomson et al. [1] reported the first success-
ful isolation of hES cells. Not only do self-renewing
pluripotent hES cells offer unprecedented hopes for tissue
regeneration, but they can also serve as an invaluable in
vitro experimental model for investigating human devel-
opment and diseases. Clearly, the ability to genetically
modify hES cells and/or their tissue-specific derivatives fur-
ther provides a flexible approach for probing the role(s) of
specific gene(s) in human development and may even lead
to “custom-tailored” hES cell-derived grafts for transplan-
tation therapies. However, conventional methods for ge-
netic manipulation (e.g., electroporation and plasmid trans-
fection) that are highly effective for mES cells prove to be
inefficient or even ineffective for hES cells. By contrast,
LV can efficiently transduce a wide range of cell types in-
cluding post-mitotic and nondividing cells [31]; indeed,
long-term LV-mediated transgene expression in hES cells
has been demonstrated [10,11,32,33].
The Cre-loxP- or tetracycline (tet)-regulated systems are
among the most commonly used inducible gene regulation
systems employed for elucidating the (developmental) roles
of target genes. Although the Cre-mediated recombination
has been successfully established in mES [34] and hES [35]
cells and is clearly a robust tool for conditional gene ex-
pression, it lacks the reversibility that is needed for tem-
porally switching on and off a given transgene. Using plas-
mid transfection, the tet-controlled system has been
employed to regulate gene expression reversibly in murine
INDUCIBLE TRANSGENE EXPRESSION IN hES CELLS
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TABLE 1. KINETIC PARAMETERS AND EC50 FOR GFP EXPRESSION OF LV-TR-KRAB-IRES-dsRed/LV-THM-GFP 
CO-TRANSDUCED mES AND hES CELLS
T50on T100on T50off T100off EC50 EC100
(hours) (days) (hours) (days) (ng/ml) (ng/ml)
mES cells 35.5  5.5 
5 71.5  2.4 
4 49.5  8.5 
300
hES cells 119.5  3.2 
10 127.7  3.9 
8 24.5  2.2 
100
T50on/off, the time at which 50% of all green cells appeared/disappeared; T100on/off, the time at which 100% of all green cells
appeared/disappeared; EC50/100, the effective concentrations at which 50%/100% of the maximum EFI was reached.
FIG. 5. (A) Representative FACS analyses of GFP expression of co-transduced human ES cells at days 7 and 14 after treatment
with different concentrations of DOX. (B) The dose–response relationships for the % of GFP human ES cells at days 7 and 14.
(C) The dose–response relationships for the MFI at the same time points. (D) The normalized dose–response relationships for MFI.
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FIG. 6. (A) Representative images of  LV-THM-Kir2.1-GFP/LV-TR-KRAB-dsRed co-transduced mouse ES cells in presence
of DOX. Bar, 50 m. (B) The inwardly rectifying IK1 was measured in DOX-treated LV-THM-Kir2.1-GFP/LV-TR-KRAB-dsRed
co-transduced but not untreated mES cells. (C) The RMP was measured by patch-clamp recordings in the presence (gray open
triangles) or absence (gray open squares) DOX. In parallel, the FMP dye was used to measure the changes of membrane poten-
tial. fluorescence (solid circles) between the untreated and DOX-treated mES cells are shown. (D) Dose-dependent relationship
for MFI of Kir2.1-GFP expression in LV-THM-Kir2.1-GFP/LV-TR-KRAB-dsRed co-transduced cells. SSEA-1 expression (E),
cell proliferation (F), and metabolism (G) as assessed by MTT assay of control and LV-THM-Kir2.1-GFP/LV-TR-KRAB-dsRed
co-transduced mES cells. (H) The RMP (left) and IK1 (right) of LV-THM-Kir2.1-GFP/LV-TR-KRAB-dsRed co-transduced hu-
man ES cells in the presence () or absence () DOX.
[9] and nonhuman primate [36] ES cells. Taking advantage
of the demonstrated ability of LV for persistent genetic
modification, here we established a reversible LV-based
tet-regulated gene expression system in hES cells. During
the preparation of this work, such a tet-inducible expres-
sion system in hES cells has been independently established
and reported [14]. In this recent study, 57% hES cells
could be induced to express GFP upon the addition of DOX.
In our experiments, up to 90% of GFP mES and hES cells
could be achieved; transgene expression was also tightly
controlled by DOX with virtually no leakage.
More importantly, the detailed dose-dependence and ki-
netics of transgene expression were investigated in our
present study. Such information is crucial for designing
future experiments in hES cells using this LV-based
inducible system. Additionally, we provide the first
demonstration that an endogenous gene can be inducibly
expressed in hES cells for altering their functional phe-
notypes. On the basis of our earlier finding that several
specialized ion channels are functionally expressed in
mES and hES cells [7], we specifically focused on their
electrophysiological properties. We have shown that the
RMP of undifferentiated mES and hES cells can be hy-
perpolarized without affecting pluripotency. Indeed, di-
rect injection of pluripotent ES cells after myocardial in-
farction has been suggested as a means to repair the
damaged heart [37]. However, transplantation of cells
with undesirable electrical properties (such as a positive
RMP) into the heart is known to predispose the recipients
to electrical disturbances by generating transmural differ-
ences that are substrates of potentially lethal arrhythmias.
Developmentally, the ion channel expression profiles of
mES and hES cells are known to undergo significant
changes during differentiation particularly for excitable
cells such as neurons and cardiomyocytes [38]. Whereas
the electrical activity per se has been demonstrated to in-
fluence the development of neurons heavily [22], similar
activity dependence has not been demonstrated for car-
diogenesis. In addition, the IK1-stabilized RMP governs
cell cycle and excitability, and plays an important role in
the development of excitable cells [13,26,27]. The system
established here presents a unique tool to investigate the
cardiac- and neural differentiation of hES cells and
thereby facilitate their future clinical applications.
In summary, we conclude that the LV-inducible sys-
tem presented here enables investigators to control the
level of target gene expression dose dependently at spe-
cific time points in hES cells during their differentiation.
Although a constitutively active promoter (EF-1) was
employed here for proof-of-concept experiments, pro-
moters that are tissue-restricted (e.g., the myosin light
chain 2v,MLC2v, and the Na/Ca2 exchanger 1, NCX1,
promoters that are specific to the heart) or germ layer-re-
stricted (e.g., the mesoderm-specific brachyury T) can be
used for probing lineage-dependent effects.
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